These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8759744)

  • 1. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus.
    Brubaker JO; Thompson CM; Morrison LA; Knipe DM; Siber GR; Finberg RW
    J Immunol; 1996 Aug; 157(4):1598-604. PubMed ID: 8759744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.
    Watanabe D; Brockman MA; Ndung'u T; Mathews L; Lucas WT; Murphy CG; Felber BK; Pavlakis GN; Deluca NA; Knipe DM
    Virology; 2007 Jan; 357(2):186-98. PubMed ID: 16996101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector.
    Hersh J; Crystal RG; Bewig B
    Gene Ther; 1995 Mar; 2(2):124-31. PubMed ID: 7719929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
    Da Costa XJ; Bourne N; Stanberry LR; Knipe DM
    Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy.
    Sudowe S; Montermann E; Steitz J; Tüting T; Knop J; Reske-Kunz AB
    Gene Ther; 2002 Jan; 9(2):147-56. PubMed ID: 11857073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
    Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
    Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen.
    Medina E; Paglia P; Rohde M; Colombo MP; Guzmán CA
    Eur J Immunol; 2000 Mar; 30(3):768-77. PubMed ID: 10741391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer in bovine blastocysts using replication-defective retroviral vectors packaged with Gibbon ape leukemia virus envelopes.
    Kim T; Leibfried-Rutledge ML; First NL
    Mol Reprod Dev; 1993 Jun; 35(2):105-13. PubMed ID: 8391277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
    Huard J; Goins WF; Glorioso JC
    Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen- and isotype-specific immune responses to a recombinant antigen-allergen chimeric (RAAC) protein.
    Zhang L; Mohapatra SS
    J Immunol; 1993 Jul; 151(2):791-9. PubMed ID: 8335908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
    Kim TS; DeKruyff RH; Rupper R; Maecker HT; Levy S; Umetsu DT
    J Immunol; 1997 May; 158(9):4137-44. PubMed ID: 9126973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
    Toda M; Martuza RL; Kojima H; Rabkin SD
    J Immunol; 1998 May; 160(9):4457-64. PubMed ID: 9574551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
    Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB
    Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile.
    Ayash-Rashkovsky M; Weisman Z; Zlotnikov S; Raz E; Bentwich Z; Borkow G
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1169-76. PubMed ID: 11302738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.